STAM expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62203583897735E-13 |
Normal-vs-Stage2 |
3.13110000149663E-08 |
Normal-vs-Stage3 |
2.77555756156289E-14 |
Normal-vs-Stage4 |
3.99680288865056E-14 |
Stage1-vs-Stage2 |
4.012000E-01 |
Stage1-vs-Stage3 |
3.261300E-03 |
Stage1-vs-Stage4 |
3.018300E-03 |
Stage2-vs-Stage3 |
2.014800E-01 |
Stage2-vs-Stage4 |
1.814210E-01 |
Stage3-vs-Stage4 |
9.971400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
4.8517000417192E-09 |
Normal-vs-Asian |
7.879300E-03 |
Caucasian-vs-AfricanAmerican |
6.833400E-01 |
Caucasian-vs-Asian |
9.398200E-01 |
AfricanAmerican-vs-Asian |
8.314400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
3.25517390820096E-12 |
Male-vs-Female |
5.678000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.10890000018615E-07 |
Normal-vs-Age(41-60Yrs) |
1.7151835507434E-12 |
Normal-vs-Age(61-80Yrs) |
1.62492241884138E-12 |
Normal-vs-Age(81-100Yrs) |
4.50940000007449E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.144600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.496400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.045800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.406600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.823200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.879200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.498300E-02 |
Normal-vs-Grade 2 |
9.20209464183586E-11 |
Normal-vs-Grade 3 |
1.69186886722628E-12 |
Normal-vs-Grade 4 |
5.55111512312578E-16 |
Grade 1-vs-Grade 2 |
2.106400E-01 |
Grade 1-vs-Grade 3 |
8.430100E-02 |
Grade 1-vs-Grade 4 |
2.418400E-02 |
Grade 2-vs-Grade 3 |
5.035100E-03 |
Grade 2-vs-Grade 4 |
3.88209999999667E-05 |
Grade 3-vs-Grade 4 |
3.962400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.23840000476605E-08 |
Normal-vs-ccB subtype |
1.63569158218024E-12 |
ccA subtype-vs-ccB subtype |
3.576000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.8748336216845E-12 |
Normal-vs-N1 |
3.583200E-04 |
N0-vs-N1 |
8.945000E-01 |
|
|